Cargando…
The Carbon Costs of In-Person Versus Virtual Medical Conferences for the Pharmaceutical Industry: Lessons from the Coronavirus Pandemic
BACKGROUND: Many in-person congresses have shifted to a virtual format owing to coronavirus disease 2019 (COVID-19). We assessed carbon emissions savings associated with virtual attendance at international medical congresses for a mid-sized pharmaceutical company, to identify which aspects are drivi...
Autores principales: | Gattrell, William T., Barraux, Aurélie, Comley, Sam, Whaley, Michael, Lander, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881751/ https://www.ncbi.nlm.nih.gov/pubmed/35218551 http://dx.doi.org/10.1007/s40290-022-00421-3 |
Ejemplares similares
-
Lessons of COVID-19: Virtual conferences
por: Houston, Stephanie
Publicado: (2020) -
In-person vs. virtual conferences: Lessons learned and how to take advantage of the best of both worlds
por: Guetter, Camila R., et al.
Publicado: (2022) -
Student Pharmacists’ Perspectives of In-Person versus Virtual Research Poster Presentations
por: Axon, David R., et al.
Publicado: (2022) -
Coronavirus versus the textile industry: cluster lessons for future challenges
por: Puig, Francisco, et al.
Publicado: (2022) -
HPLC in the pharmaceutical industry /
Publicado: (1991)